- Home
- LNG vs ALC Comparison
LNG vs ALC Comparison
Compare LNG & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNG
- ALC
- Stock Information
- Founded
- LNG 1983
- ALC 1945
- Country
- LNG United States
- ALC Switzerland
- Employees
- LNG N/A
- ALC N/A
- Industry
- LNG Oil/Gas Transmission
- ALC Ophthalmic Goods
- Sector
- LNG Utilities
- ALC Health Care
- Exchange
- LNG Nasdaq
- ALC Nasdaq
- Market Cap
- LNG 52.2B
- ALC 43.2B
- IPO Year
- LNG 1997
- ALC N/A
- Fundamental
- Price
- LNG $225.44
- ALC $91.84
- Analyst Decision
- LNG Strong Buy
- ALC Buy
- Analyst Count
- LNG 14
- ALC 10
- Target Price
- LNG $255.64
- ALC $106.88
- AVG Volume (30 Days)
- LNG 2.0M
- ALC 1.5M
- Earning Date
- LNG 08-07-2025
- ALC 08-19-2025
- Dividend Yield
- LNG 0.89%
- ALC 0.24%
- EPS Growth
- LNG N/A
- ALC 6.66
- EPS
- LNG 13.71
- ALC 2.25
- Revenue
- LNG $16,739,000,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- LNG $33.97
- ALC $6.22
- Revenue Next Year
- LNG $13.92
- ALC $7.16
- P/E Ratio
- LNG $16.44
- ALC $40.42
- Revenue Growth
- LNG N/A
- ALC 3.80
- 52 Week Low
- LNG $167.66
- ALC $80.48
- 52 Week High
- LNG $257.65
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- LNG 42.69
- ALC 65.27
- Support Level
- LNG $221.00
- ALC $87.06
- Resistance Level
- LNG $228.13
- ALC $92.55
- Average True Range (ATR)
- LNG 5.68
- ALC 1.35
- MACD
- LNG -1.47
- ALC 0.60
- Stochastic Oscillator
- LNG 18.08
- ALC 89.90
About LNG Cheniere Energy Inc.
Cheniere Energy is a liquified natural gas, or LNG, producer with two facilities in Corpus Christi, Texas and Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed and variable fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. A subsidiary, Cheniere Energy Partners, owns the Sabine Pass facility and trades as a master limited partnership.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.